Shi-Xuan Wang
Overview
Explore the profile of Shi-Xuan Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Huang Z, Li J, Wu Y, Du J, Li T
Front Med (Lausanne)
. 2024 Nov;
11:1487234.
PMID: 39574909
Background: Optimizing the diagnosis and treatment of hematological diseases is a challenging yet crucial research area. Effective treatment plans typically require the comprehensive integration of cell morphology, immunology, cytogenetics, and...
2.
Tu Y, Wang S, Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2024 Oct;
32(5):1608-1613.
PMID: 39479855
Myeloproliferative neoplasms (MPN) are a group of malignant myeloid tumors caused by hematopoietic stem cell proliferation. The discovery of gene mutations has elucidated the pathogenesis of MPN and provided molecular...
3.
Wang S, Wang F, Tu Y, Zhou Y, Tu S, Wang J, et al.
Ann Hematol
. 2024 Aug;
103(10):4319-4323.
PMID: 39105740
Chronic neutrophil leukemia (CNL) is a rare and life-threatening disease. Cases of CNL combined with lymphoma are rare. Here, we report a case of CNL with T-acute lymphoblastic leukemia/lymphoma (T-ALL/LBL)...
4.
Chen Z, Wang S, Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2024 Feb;
32(1):308-312.
PMID: 38387940
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm with splenomegaly as the major clinical manifestation, which is commonly considered to be linked to splenic extramedullary hematopoiesis. Alteration of CXCL12/CXCR4 pathway can...
5.
Wu T, Huang K, Yan J, Zhang J, Wang S
Hum Reprod Open
. 2023 May;
2023(2):hoad014.
PMID: 37180603
Study Question: What is the current state-of-the-art methodology assessing decellularized extracellular matrix (dECM)-based artificial ovaries for treating ovarian failure? Summary Answer: Preclinical studies have demonstrated that decellularized scaffolds support the...
6.
Li Y, Li Y, Wang S, Ma X
Curr Med Sci
. 2023 Apr;
43(3):539-550.
PMID: 37119369
Objective: This study aimed to explore the value of M701, targeting epithelial cell adhesion molecule (EpCAM) and CD3, in the immunotherapy of ovarian cancer ascites by the in vitro assay....
7.
Zhang Y, Fang J, Tu S, Chen Z, Xie W, Luo A, et al.
Curr Med Sci
. 2023 Apr;
43(2):284-296.
PMID: 37059935
Objective: Diminished ovarian reserve (DOR) can lead to early menopause, poor fecundity, and an increased risk of disorders such as osteoporosis, cardiovascular disease, and cognitive impairment, seriously affecting the physical...
8.
Wu T, Gao Y, Tang X, Zhang J, Wang S
J Funct Biomater
. 2022 Oct;
13(4).
PMID: 36278634
Substitution by artificial ovary is a promising approach to restore ovarian function, and a decellularized extracellular matrix can be used as a supporting scaffold. However, biomimetic ovary fabrication and immunogenicity...
9.
Wu T, Gao Y, Tang X, Li Y, Dai J, Zhou S, et al.
Hum Reprod
. 2022 Oct;
37(12):2856-2866.
PMID: 36223608
Study Question: Would the construction of a competing endogenous RNA (ceRNA) network help identify new drug targets for the development of potential therapies for polycystic ovary syndrome (PCOS)? Summary Answer:...
10.
Kang J, Wang S, Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2022 Jun;
30(3):959-964.
PMID: 35680834
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease caused by uncontrolled proliferation of activated macrophage, and secreting high amounts of inflammatory cytokines which lead to multi-organ dysfunction syndrome. HLH patients often...